Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer.

Dockery, Lauren E; Rubenstein, Abby R; Ding, Kai; Mashburn, Sarah G; Burkett, Wesley C; Davis, Allison M; Doo, David W; Arend, Rebecca C; Moore, Kathleen N; Gunderson, Camille C

Dockery, Lauren E; Rubenstein, Abby R; Ding, Kai; Mashburn, Sarah G; Burkett, Wesley C; Davis, Allison M; Doo, David W; Arend, Rebecca C; Moore, Kathleen N; Gunderson, Camille C.

Afiliação

Dockery LE; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America. Electronic address: lauren_dockery@unchealth.unc.edu.
Rubenstein AR; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Ding K; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Mashburn SG; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Burkett WC; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Davis AM; University of Alabama, Birmingham, AL, United States of America.
Doo DW; University of Alabama, Birmingham, AL, United States of America.
Arend RC; University of Alabama, Birmingham, AL, United States of America.
Moore KN; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Gunderson CC; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.

Gynecol Oncol ; 155(2): 201-206, 2019 11.

Article em En | MEDLINE | ID: mdl-31522837

Assuntos

Antineoplásicos/uso terapêutico; Neoplasias Ovarianas/tratamento farmacológico; Compostos de Platina/uso terapêutico; Adulto; Idoso; Idoso de 80 Anos ou mais; Bevacizumab/uso terapêutico; Progressão da Doença; Intervalo Livre de Doença; Feminino; Humanos; Pessoa de Meia-Idade; Terapia de Alvo Molecular/métodos; Terapia de Alvo Molecular/mortalidade; Recidiva Local de Neoplasia/etiologia; Recidiva Local de Neoplasia/mortalidade; Neoplasias Ovarianas/mortalidade; Estudos Retrospectivos; Resultado do Tratamento

Palavras-chave

Chemotherapy; MITO-8; Ovarian cancer; PFI; Platinum sensitivity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Compostos de Platina / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google